A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
Clinical trial NCT02987114 · COMPLETED
Trial details
- NCT number
- NCT02987114
- Sponsor
- PhytoTech Therapeutics, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2018-06-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.